Market Place
Sourcing Support
AGC to use recently-expanded Germany site for peanut allergy drug trials
01 Apr 2022 //
ENDPTS
Allergy Selects AGC Biologics to Manufacture Peanut Allergy Vaccine Candidate
31 Mar 2022 //
PRESS RELEASE
FDA Clears Allergy`s IND for peanut allergy vaccine candidate VLP Peanut
26 Jan 2022 //
GLOBENEWSWIRE
Allergy Therapeutics announces Positive Data for VLP Peanut 001 trial
13 Sep 2021 //
INVESTEGATE
Allergy Therapeutics announces successful primary outcome of VLP Peanut 001
03 Aug 2021 //
INVESTEGATE
Allergy Therapeutics announces completion of treatment phase in innovative G309
06 May 2021 //
DIRECTORSTALKINTERVIEWS
Allergy Therapeutics announces start of innovative exploratory field study
26 Oct 2020 //
PIPELINEREVIEW
Allergy Therapeutics announces invalidation of the Birch MATA MPL Phase III
09 Jul 2020 //
INVESTEGATE
Allergy Therapeutics plc - Successful litigation settlement
27 Jun 2019 //
GLOBE NEWSWIRE
Positive Phase I results for Allergy’s Acarovac
21 May 2019 //
PHARMA TIMES
Allergy`s publishes new research illustrating Group`s adjuvant systems portfolio
07 May 2019 //
BIOSPECTRUMASIA
Allergy Therapeutics kicks off dosing in grass immunotherapy trial
19 Oct 2017 //
PHARMA TIMES
Allergy Therapeutics eyes 15% sales jump
18 Jul 2017 //
PHARMA TIMES
Allergy Therapeutics fails to find optimal dose in PhII, delays PhIII
28 Jun 2016 //
FIERCE BIOTECH
Allergy Therapeutics plc Race with Positive Phase II Data for Hayfever
09 May 2016 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.